PPBT (Purple Biotech Ltd. American Depositary Shares) Stock Analysis - SEC Filings

Purple Biotech Ltd. American Depositary Shares (PPBT) is a publicly traded Healthcare sector company. As of May 21, 2026, PPBT trades at $2.75 with a market cap of $3.51M and a P/E ratio of 0.00. PPBT moved -11.11% today. Year to date, PPBT is -57.03%; over the trailing twelve months it is -87.63%. Its 52-week range spans $2.71 to $139.50. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PPBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find PPBT SEC filings?

Rallies organizes PPBT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

PPBT Key Metrics

Key financial metrics for PPBT
MetricValue
Price$2.75
Market Cap$3.51M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$139.50
52-Week Low$2.71
Volume11.76K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PPBT News

PPBT Analyst Consensus

1 analysts cover PPBT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.

Common questions about PPBT

Where can I find PPBT SEC filings?
Rallies organizes PPBT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show PPBT 10-K and 10-Q filings?
Rallies organizes PPBT SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is PPBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PPBT. It does not provide personalized investment advice.
PPBT

PPBT